Case Western Reserve researchers use AI with routine CT scans to predict how well lung cancer patients will respond to expensive treatment based off changes in texture patterns inside and outside the tumor.
Scientists from the Case Western Reserve University digital imaging lab, already pioneering the use of Artificial Intelligence (AI) to predict whether chemotherapy will be successful, can now determine which lung-cancer patients will benefit from expensive immunotherapy.
And, once again, they’re doing it by teaching a computer to find previously unseen changes in patterns in CT scans taken when the lung cancer is first diagnosed compared to scans taken after the first 2-3 cycles of immunotherapy treatment. And, as with previous work, those changes have been discovered both inside—and outside—the tumor, a signature of the lab’s recent research.
“This is no flash in the pan—this research really seems to be reflecting something about the very biology of the disease, about which is the more aggressive phenotype, and that’s information oncologists do not currently have,” said Anant Madabhushi, whose Center for Computational Imaging and Personalized Diagnostics (CCIPD) has become a global leader in the detection, diagnosis and characterization of various cancers and other diseases by meshing medical imaging, machine learning and AI.
Currently, only about 20% of all cancer patients will actually benefit from immunotherapy, a treatment that differs from chemotherapy in that it uses drugs to help your immune system fight cancer, while chemotherapy uses drugs to directly kill cancer cells, according to the National Cancer Institute.
Madabhushi said the recent work by his lab would help oncologists know which patients would actually benefit from the therapy, and who would not.
“Even though immunotherapy has changed the entire ecosystem of cancer, it also remains extremely expensive—about $200,000 per patient, per year,” Madabhushi said. “That’s part of the financial toxicity that comes along with cancer and results in about 42% of all new diagnosed cancer patients losing their life savings within a year of diagnosis.”
Having a tool based on the research being done now by his lab would go a long way toward “doing a better job of matching up which patients will respond to immunotherapy instead of throwing $800,000 down the drain,” he added, referencing the four patients out of five who will not benefit, multiplied by annual estimated cost.
New research published
The new research, led by co-authors Mohammadhadi Khorrami and Prateek Prasanna, along with Madabhushi and 10 other collaborators from six different institutions (see list, below) was published this month in the journal Cancer Immunology Research.
Khorrami, a graduate student working at the CCIPD, said one of the more significant advances in the research was the ability of the computer program to note the changes in texture, volume and shape of a given lesion, not just its size.
“This is important because when a doctor decides based on CT images alone whether a patient has responded to therapy, it is often based on the size of the lesion,” Khorrami said. “We have found that textural change is a better predictor of whether the therapy is working.
“Sometimes, for example, the nodule may appear larger after therapy because of another reason, say a broken vessel inside the tumor—but the therapy is actually working. Now, we have a way of knowing that.”
Prasanna, a postdoctoral research associate in Madabhushi’s lab, said the study also showed that the results were consistent across scans of patients treated at two different sites and with three different types of immunotherapy agents.
“This is a demonstration of the fundamental value of the program, that our machine-learning model could predict response in patients treated with different immune checkpoint inhibitors,” he said. “We are dealing with a fundamental biological principal.”
Prasanna said the initial study used CT scans from 50 patients to train the computer and create a mathematical algorithm to identify the changes in the lesion. He said the next step will be to test the program on cases obtained from other sites and across different immunotherapy agents. This research recently won an ASCO 2019 Conquer Cancer Foundation Merit Award.
Additionally, Madabhushi said, researchers were able show that the patterns on the CT scans which were most associated with a positive response to treatment and with overall patient survival were also later found to be closely associated with the arrangement of immune cells on the original diagnostic biopsies of those patients.
This suggests that those CT scans actually appear to capturing the immune response elicited by the tumors against the invasion of the cancer—and that the ones with the strongest immune response were showing the most significant textural change and most importantly, would best respond to the immunotherapy, he said.
Madabhushi established the CCIPD at Case Western Reserve in 2012. The lab now includes nearly 60 researchers.
Some of the lab’s most recent work, in collaboration with New York University and Yale University, has used AI to predict which lung cancer patients would benefit from adjuvant chemotherapy based on tissue-slide images. That advancement was named by Prevention Magazine as one of the top 10 medical breakthroughs of 2018.
The Latest Google Headlines on:
The Latest Bing News on:
- Severe Side Effects of Leukemia CAR-T Immunotherapy Can Be Turned off With a Specially Engineered Safety Switchon March 4, 2021 at 1:23 pm
Severe side effects of leukemia CAR-T immunotherapy can be turned off with a specially engineered safety switch ...
- Society for Immunotherapy of Cancer to Host Virtual Leadership Institute Focusing on Professional Development of Women in Cancer Immunotherapyon March 4, 2021 at 12:15 pm
The Society for Immunotherapy of Cancer (SITC) is pleased to announce the return of a successful initiative focused on women in the field. The ...
- Engineered safety switch curbs severe side effects of CAR-T immunotherapyon March 4, 2021 at 7:53 am
UNC Lineberger Comprehensive Cancer Center researchers have successfully used an experimental safety switch, incorporated as part of a chimeric antigen receptor T-cell (CAR-T) therapy, a type of ...
- Funding the Future of Cancer Research: The Parker Institute for Cancer Immunotherapy Awards Nearly $3 Million to Six Early Career Researcherson March 3, 2021 at 7:17 pm
From improving immunotherapy response in childhood cancer patients, to better understanding how cancer's spread to the liver affects the body's immune system, to helping T cells stay energized to ...
- Immunotherapy Boost May Come from Dendritic Cell Factorieson March 3, 2021 at 2:30 pm
Study details how stem cells give rise to cancer-fighting dendritic cells that could lead to "dendritic cell factories" and better immunotherapies.
- Sequential administration of immunotherapy and targeted therapy prolongs anti-tumor responseson March 2, 2021 at 5:08 pm
Advanced melanoma is one of the deadliest types of cancer, with a 5-year survival rate of only 27% for patients with distant metastases.
- Cancer Immunotherapy Market Segmented by Product, Top Manufacturers, Geography Trends & Forecasts to 2025on March 2, 2021 at 1:32 pm
Selbyville, Delaware According to Market Study Report, Cancer Immunotherapy Market provides a comprehensive analysis of the Cancer Immunotherapy market segments, including their dynamics, size, growth ...
- Sequential treatment with immunotherapy and checkpoint inhibitors prolongs anti-tumor activityon March 2, 2021 at 9:00 am
Advanced melanoma is one of the deadliest types of cancer, with a 5-year survival rate of only 27% for patients with distant metastases. Recent advances in targeted therapies and immunotherapies have ...
- T cell atlas reveals route to glioma immunotherapyon March 2, 2021 at 7:40 am
Immunotherapy is revolutionizing cancer treatment, but its success in glioblastoma (GBM) is lagging behind that seen in other cancer types. Writing in Cell, Mathewson et al. now identify CD161 as an ...
- Researchers develop mutant gene-targeted immunotherapy approach to fight cancerson March 1, 2021 at 3:30 pm
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg~Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel ...
The Latest Google Headlines on:
Artificial intelligence diagnostics
The Latest Bing News on:
Artificial intelligence diagnostics
- ClinSpec Diagnostics Closes £3.5M Fundingon March 4, 2021 at 3:14 am
ClinSpec Diagnostics Limited, a Glasgow, Scotland, UK-based developer of liquid biopsies for early detection of cancer, secured an additional funding of £1.1M and closed its target of £3.5M ...
- Artificial Intelligence Moving Towards Brighter Future in Healthcare Industryon March 4, 2021 at 12:20 am
The artificial intelligence in healthcare market is expected to witness substantial growth post-pandemic. The global healthcare infrastructure has observed that, in order to develop and maintain ...
- Artificial Intelligence (AI) in Healthcare Market to reach US$ 107,797.82 million by 2027 – Arterys, Alphabet, Nuance Communications, Intelon March 3, 2021 at 3:50 pm
Lucrative Regions for Artificial Intelligence in Healthcare Market” Artificial intelligence in healthcare market was valued at US$ 3,991.23 million in 2019 and ...
- Artificial Intelligence in Healthcare Market worth $45.2 billion by 2026, at a CAGR of 44.9%on March 3, 2021 at 3:25 pm
According to the new market research report on the “Artificial Intelligence in Healthcare Market with Covid-19 Impact Analysis by Offering (Hardware, Software, Services), Techno ...
- BioIQ Launches New Telehealth Solution for Diagnostic Testing and Population Healthon March 3, 2021 at 8:19 am
BioIQ, an analytics-driven population health and testing platform company for top employers and health plans, announces the launch of an integrated telehealth offering procured through the acquisition ...
- 4 Reasons Why Workers Should Welcome Artificial Intelligence In the Workplaceon March 2, 2021 at 1:18 pm
We are also witnessing a significant rise in interest for robotic process automation (RPA), intelligent automation and artificial intelligence among business leaders who realize that intelligent ...
- Decorté Partners with Perfect Corp. to Launch YouCam's New Artificial Intelligence-Driven Skincare Diagnostic Technology That Debuted At CES 2021on March 2, 2021 at 5:16 am
Decorté, a leader in Japanese beauty and a pioneer in cutting edge dermatological research and skincare technology, is launching Perfect Corp.'s new AI skincare diagnostic technology in the US and is ...
- More Indian Healthcare Firms to Harness the Power of Artificial Intelligenceon March 2, 2021 at 12:24 am
Recent reports observe that India’s many healthcare firms are now looking at harnessing the power of Artificial Intelligence.
- Artificial Intelligence: Leveling The Business Playing Fieldon February 25, 2021 at 5:20 am
Covid-19 has catalyzed the accelerated adoption of AI-based business analytics, workflow and process automation.
- Artificial Intelligence Market Size, Share, Sales Volume and Revenue Growth Analysis Research Report 2026on February 24, 2021 at 9:16 pm
The artificial intelligence market in North America is set for rapid growth. The growth witnessed in this region ...